Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops

Clinical trial NCT06969001 · COMPLETED

Trial details

NCT number: NCT06969001
Sponsor: SCAI Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Wet Age Related Macular Degeneration

Start date: 2025-05-29
Primary completion: 2025-09-04
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.